Open an account

Inspire Medical Systems

INSP · NYSE

$71.34+$1.19 (+1.70%)TodayMarket closed ·
Prev close $70.15

About INSP

Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota and currently employs 1,333 full-time employees. The company went IPO on 2018-05-03. The firm focuses on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is neurostimulation technology that provides safe and effective treatment for moderate to severe obstructive sleep apnea. The firm's closed-loop solution continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.

Employees
1,333
Headquarters
Golden Valley, Minnesota
Listed
May 3, 2018
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
inspiresleep.com

INSP key statistics

Market cap
2.03B
Price-earnings ratio
15.45
Dividend yield
—
Average volume
907.33K
Volume
234.86K
Open price
$71.01
High today
$71.90
Low today
$70.00
52 Week high
$147.03
52 Week low
$38.91

Inspire Medical Systems (INSP) at a glance

As of Oct 20, 2026, Inspire Medical Systems (INSP) shares are priced at $71.34, giving the company a market cap of 2.03B and a price-to-earnings ratio of 15.45.

Today the stock has traded between $70.00 and $71.90. The current price is 1.9% above the day's low and 0.8% below its high.

Volume so far is 234.86K shares, below the average of 907.33K shares a day.

Over the past year Inspire Medical Systems has ranged from $38.91 to $147.03, and now sits 30% of the way up that range.

Inspire Medical Systems met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.01 per share against an estimate of -$0.2764.

The average analyst price target is $71.53, 0.3% above the current price, from 17 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

24%of 17 analyst ratings say Buy
  • Buy23.5%
  • Hold64.7%
  • Sell11.8%
Price target · 19 analystsAvg $71.53
Low
$40.40
Now
$71.34
High
$189.00

INSP earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 206.6% on average.

  1. Q3 FY24: reported $0.60 per share against an estimate of $0.0768
  2. Q4 FY24: reported $1.15 per share against an estimate of $0.7464
  3. Q1 FY25: reported $0.10 per share against an estimate of -$0.2532
  4. Q2 FY25: reported $0.45 per share against an estimate of $0.2098
  5. Q3 FY25: reported $0.34 per share against an estimate of -$0.198
  6. Q4 FY25: reported $1.62 per share against an estimate of $0.8934
  7. Q1 FY26: reported -$0.39 per share against an estimate of -$0.2834
  8. Q2 FY26: reported $0.01 per share against an estimate of -$0.2764

INSP news

  • Press releaseBusiness Wire

    Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • 12 Health Care Stocks Moving In Monday's After-Market Session

  • Press releaseBusiness Wire

    Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP

  • Press releasePRNewswire

    Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP

  • Press releaseBusiness Wire

    Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP

  • Rishabh Mishra

    Stock Market Today: Dow, S&P 500, Nasdaq Futures Rise As Traders Monitor US-Iran Ceasefire— Duolingo, Pinterest, AMD In Focus (UPDATED)

  • Full Transcript: Inspire Medical Systems Q1 2026 Earnings Call

Similar companies

Companies in the same industry as Inspire Medical Systems

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.